Hyman Charles D Matinas Bio Pharma Holdings, Inc. Transaction History
Hyman Charles D
- $1.79 Billion
- Q2 2024
A detailed history of Hyman Charles D transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Hyman Charles D holds 79,800 shares of MTNB stock, worth $56,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,800
Previous 79,800
-0.0%
Holding current value
$56,658
Previous $21,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MTNB
# of Institutions
15Shares Held
4.61MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.48MShares$1.76 Million0.0% of portfolio
-
Jtc Employer Solutions Trustee LTD775KShares$550,2500.0% of portfolio
-
Kingsbury Capital Investment Advisors LLC Evanston, IL120KShares$85,1630.12% of portfolio
-
Jane Street Group, LLC New York, NY103KShares$73,4130.0% of portfolio
-
Sawtooth Solutions, LLC60KShares$42,6110.0% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $154M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...